Hopes -- And Questions -- Are Raised By Study Of French Biotech ' s ALS Drug

A new drug developed by a small French biotechnology company appears to slow amyotrophic lateral sclerosis, or ALS, by 27%, providing another new weapon against the deadly neurodegenerative disease. But researchers were reticent about the data, saying another study may be needed.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Source Type: news